Zobrazeno 1 - 10
of 20
pro vyhledávání: '"L I, Kazak"'
Publikováno v:
Likars'ka sprava. (3)
The paper summarizes the literature data and the authors' own investigations on cardiotropic and clinical-pharmacological properties of Mildronat. The medication normalizes energy metabolism, optimizes the functions of the heart, and improves the hea
Autor:
I S, Chekman, L I, Kazak
Publikováno v:
Likars'ka sprava. (10-12)
Autor:
I S, Chekman, L I, Kazak
Publikováno v:
Likars'ka sprava. (7)
Autor:
L I, Kazak
Publikováno v:
Vrachebnoe delo. (9)
Autor:
L I, Kazak
Publikováno v:
Vrachebnoe delo. (7)
Autor:
I S, Chekman, L I, Kazak
Publikováno v:
Vrachebnoe delo. (4)
Autor:
L I, Kazak, S B, Frantsuzova
Publikováno v:
Fiziolohichnyi zhurnal. 24(3)
Publikováno v:
Kardiologiia. 21(3)
Examination of 94 patients with stage II hypertensive disease and 20 rabbits with hypertension showed that in the hypokinetic type of hemodynamics separate medication with dibazol, papaverin hydrochloride and reserpine caused a reduction of arterial
Publikováno v:
Kardiologiia. 16(5)
Experimental thyrotoxicosis was induced in rats and rabbits. The content of catecholamines was significantly decreasing in the myocardium of rabbits in the presence of severe thyroidine-induced toxicosis. The noradrenaline concentration was especiall
Publikováno v:
Fiziologicheskii zhurnal. 35(6)
The effects of dibasol on spontaneous electrical and contractile activities as well as on the reactions evoked by hyperkalemic solution and noradrenaline were studied in smooth muscle of rabbit portal vein. It was shown that dibasol blocked the poten